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SUPPLEMENTARY METHODS 
Genetic analysis 
Whole-exome sequencing (WES) was performed on 50ng of genomic DNA extracted 
from peripheral blood of 4 cases (A-5, B-1 & 2 and C-1). Library preparation was 
completed using the Illumina Nextera Rapid Capture Exome Library Preparation Kit. 
Sequencing was completed using the Illumina HiSeq 1000 platform. Sequence data 
were mapped using Galaxy (1-3) and Human Genome Reference Consortium build 
37/ hg19 (GRCh37/hg19) as a reference. Over 95% of reads were aligned to the 
reference genome. SNPs were called using wANNOVAR (4).  
Homozygosity mapping was performed in the index case of family A (A-5), the 
parents, the symptomatic sibling and the asymptomatic siblings by using the Illumina 
CytoSNP12 SNP array and analysed using Illumina Genome Studio 2011.1 software 
with loss of heterozygosity detector plug in to identify runs of homozygosity (version 
1.9.0).  
Sanger sequencing for CECR1 was performed using the primers shown in table S-1. 
FastStart PCR Master mix (Roche) was used for amplification and BigDye 
Terminator V3.1 Cycle Sequencing Kit (Applied Biosystem) was used for the 
sequencing reaction. Sanger sequencing was performed using the Applied 
Biosystems 3730 DNA Analyzer and calls were made using Applied Biosystem 5.2 
software. The sequencing output was analysed using CodonCode Aligner 5.1 to 
align and visualize the reads.  
Table S-1 Sequences of forward and reverse primers used for Sanger 
sequencing of all the exons and untranslated regions of CECR1 
 
 Forward primer Reverse  Primer 
1 TTGGTGTGAAGAAAGGGATG TGTGTGATGTTCCCCTTGAA 
2 CAGGGCGAGAAAAGGAAGAT TGAGGCTTTCTCTGCTCCAT 
3 GACTTCACCCCCTCCTTTGT GCTGGGATTATAGGCGTGAA 
4 AAGTTCGTCGCTTTCCTCAC TATGCACTCCCACACCAAGA 
5 TTTGGGTTTAAGCAGGCAGT TCCATTTCAGGTTTCCTTGC 
6 CCCCTGACCCCATCTACTTT GGACTGTGCTCTCACACAGG 
7 GCCAGCAAGGGTCTTTGATA GGGCTGGTGAGGGTTTTAAG 
8 GGCTGTAGTGCATTGGTGTG ACAGGAAAGGGCTCTGGAAA 
9 GGAAACTGTGTGTGTGTATTTGTG GCAAAAAGTTTAAGAGAGCAGAGG 
10 GGAGCTGATGGGGCTCAA ACCCACAGGAACCATCGAG 
11 TGGCTGTTTAGTCCTTGCTG TGTGAGCTCTCCAAGTGCAT 
12 ATGCCTGGCCTATTCTGGTC GGACCACGAGGTCAGGTG 
13 GGTTCAAGCGGATTCTCGT TTCTTTGATTCCCTGCCATC 
 
Adenosine deaminase 2 assay  
Diazyme's ADA Assay is based on the enzymatic deamination of adenosine to 
inosine which is converted to hypoxanthine by purine nucleoside phosphorylase 
(PNP). Hypoxanthine is then converted to uric acid and hydrogen peroxide 
(H2O2) by xanthine oxidase (XOD). H2O2 is further reacted with N-Ethyl-N-(2-
hydroxy-3-sulfopropyl)-3-methylaniline (EHSPT) and 4-aminoantipyrine (4-AA) 
in the presence of peroxidase (POD) to generate quinone dye which is 
monitored in a kinetic manner. One unit of ADA was defined as the amount of 
ADA that generates one μmole of inosine from adenosine per minute at 37°C. 
This kit cannot differentiate the function of ADA type 1 or 2. In order to 
specifically measure ADA2 activity, 100 nM of specific ADA1 inhibitor; erythro-9-
(2-hydroxy-3-nonyl) adenine (EHNA), was added during the assay. Reading of 
the absorbance of the enzyme activity using the Fluorstar Optima 
spectrophometer at wavelength 540 nm with lens. Intra-test coefficient of 
variation (CV) is < 4.5% and inter-test CV is < 5% (manufacturer’s product 
sheet). 
 
SUPPLEMENTARY RESULTS 
 
Figure S-1 Family tree of family B, C and G. All genotypes identified by Sanger 
sequencing. WT: wild type  
A: Family B. Patient B-1 and B-2 have homozygous p.Gly47Arg (p.G47R/ 
p.G47R) mutations and the parents are heterozygous for this variant 
(p.G47R/WT).  
B: Family C. Patient C-1 and C-2 have compound heterozygous 
p.Pro251Leu/c.-114DelC (P251L/c.-114DelC) mutations. The mother and 
healthy sister are heterozygous (P251L/WT), and the father is heterozygous (c.-
114DelC/WT).  
C: Family G. Patient G-1 and G-2 were homozygous for the mutation 
p.Arg169Gln (p.R169Q/ p.R169Q), no samples from the parents were available 
for sequencing. 

Table S-2: Histopathological and angiographic findings in 9 symptomatic DADA2 patients  
Patient Histopathological features Angiographic findings 
A-5 Sural nerve biopsy|: Epineurial vessels were  
infiltrated by inflammatory cells with associated 
disruption of the elastic lamina, patchy active and 
mild axonal 
neuropathy with minimal regeneration 
MRA whole aorta: Normal 
B-1 Skin biopsy: reactive endothelial changes with 
distortion of the capillary luminae, segmented 
leucocyte and lymphocytic cuffing and associated 
mild perivascular oedema. 
NA 
B-2 Skin biopsy: infiltration of neutrophils and 
eosinophils with leucocytoclasis in dermal blood 
vessels with destruction of vessels 
MRI/MRA brain and brain stem normal 
C NA MRI of the leg with contrast: multiple tortuous blood 
vessels with phlebolith within 
D NA DSA: truncation and beading with multiple 
microaneurysms in intrarenal arteries, jejunal branches 
of superior mesenteric artery and intrahepatic arteries.  
E Skin biopsy: thrombosis, with fibrin deposition 
within the wall and concentric active inflammation 
with plasma cells, lymphocytes and neutrophils in 
subcutis blood vessels 
DSA: multiple microaneurysms in both kidneys and in 
the liver  
 
F NA MRA: multiple aneurysmal dilatation of the small intra-
renal vessels  
DSA: multiple microaneurysms in both kidneys 
G-1 Skin biopsy: normal MRA brain (6 years old): Cerebral haemorrhage at right 
frontal area with multiple pseudoaneurysms in left 
basofrontal area.  
MRA brain (6 1/2 years old):multiple infarctions in pons 
G-2 Skin biopsy: normal MRA brain: Acute hemorrhagic stroke left basal ganglia 
with hemiplegia and transient aphasia, no evidence of 
aneurysms 
 DSA: digital subtraction angiography, MRA: magnetic resonance angiogram, NA: not applicable
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